Literature DB >> 12409374

Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population.

David J Diemert1, Michael D Libman, Pierre Lebel.   

Abstract

The COBAS AMPLICOR CT/NG test is widely used for the diagnosis of Neisseria gonorrhoeae infection using genital swabs or urine samples. Although highly specific, cross-reactivity occurs with some nonpathogenic strains of Neisseria and Lactobacillus species. In low-prevalence populations, even highly specific assays may require confirmatory testing of positive results. We assessed the positive predictive value (PPV) of this test in a low-prevalence (0.5%) setting. Genital and urine specimens testing positive using the COBAS AMPLICOR NG test were retested using an investigational 16S rRNA PCR assay. Additionally, 737 specimens were tested in parallel by both culture and the above PCR protocol. Of 9,772 specimens tested in-house, 168 were positive by the AMPLICOR test; in addition, 62 AMPLICOR-positive specimens were referred to our laboratory for confirmatory testing, yielding 230 positive specimens. Of these, 72 were confirmed positive by 16S rRNA PCR, yielding a specificity of 98.7% and a PPV of 31.3%. Specificity was similar for all specimen types, whereas PPV varied with prevalence: specimens from males, females, urine specimens, and genital swabs had PPVs of 70.8, 13.3, 51.9, and 20.1%, respectively. The PPV was higher when the initial AMPLICOR optical density (OD) was > or =3.5 versus initial and repeat OD readings in an equivocal zone of > or =0.2 to <3.5 (65.1 versus 10.1%; P < 0.001). On repeat testing of specimens with ODs in the equivocal zone, 54 gave ODs of > or =0.2 and <2.0, 35 gave ODs of > or =2.0 and <3.5, and 12 gave ODs of > or =3.5, with 3.7, 20, and 33.3% confirmed positive, respectively (P = 0.004). Comparing PCR to culture as the "gold standard," specificity increased from 96.8 to 99.9% when 16S rRNA PCR was performed on specimens positive by the COBAS AMPLICOR NG test. Confirmatory testing with a more specific method such as 16S rRNA PCR should be considered in low-prevalence populations, especially for specimens with an OD in the equivocal zone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409374      PMCID: PMC139689          DOI: 10.1128/JCM.40.11.4056-4059.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis.

Authors:  T A Green; C M Black; R E Johnson
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay.

Authors:  K A Crotchfelt; L E Welsh; D DeBonville; M Rosenstraus; T C Quinn
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Comparison of Roche Cobas Amplicor and Abbott LCx for the rapid detection of Chlamydia trachomatis in specimens from high-risk patients.

Authors:  O Steingrímsson; K Jónsdóttir; J H Olafsson; S M Karlsson; R Pálsdóttir; S Davídsson
Journal:  Sex Transm Dis       Date:  1998-01       Impact factor: 2.830

5.  Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.

Authors:  M Puolakkainen; E Hiltunen-Back; T Reunala; S Suhonen; P Lähteenmäki; M Lehtinen; J Paavonen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR.

Authors:  D J Farrell
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

7.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.

Authors:  K R Smith; S Ching; H Lee; Y Ohhashi; H Y Hu; H C Fisher; E W Hook
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.

Authors:  S Ching; H Lee; E W Hook; M R Jacobs; J Zenilman
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J Vincelette; J Schirm; M Bogard; A M Bourgault; D S Luijt; A Bianchi; P C van Voorst Vader; A Butcher; M Rosenstraus
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Evaluation of the abbott LCx assay for detection of Neisseria gonorrhoeae in endocervical swab specimens from females.

Authors:  S C Kehl; K Georgakas; G R Swain; G Sedmak; S Gradus; A Singh; S Foldy
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more
  17 in total

1.  Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers.

Authors:  J Pépin; A-C Labbé; N Khonde; S Deslandes; M Alary; A Dzokoto; C Asamoah-Adu; H Méda; E Frost
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

2.  Asymptomatic men: should they be tested for urethritis?

Authors:  Paddy Horner
Journal:  Sex Transm Infect       Date:  2007-04       Impact factor: 3.519

3.  Pyrosequencing of the DNA gyrase gene in Neisseria species: effective indicator of ciprofloxacin resistance in Neisseria gonorrhoeae.

Authors:  Emma Lindbäck; Magnus Unemo; Michael Akhras; Baback Gharizadeh; Hans Fredlund; Nader Pourmand; Bengt Wretlind
Journal:  APMIS       Date:  2006-12       Impact factor: 3.205

Review 4.  Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge.

Authors:  David M Whiley; John W Tapsall; Theo P Sloots
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

5.  Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species.

Authors:  Sepehr N Tabrizi; Magnus Unemo; Athena E Limnios; Tiffany R Hogan; Stig-Ove Hjelmevoll; Susanne M Garland; John Tapsall
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

6.  Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin.

Authors:  M Alary; C Gbenafa-Agossa; G Aïna; M Ndour; A C Labbé; D Fortin; M Steele; R W Peeling
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

7.  A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene.

Authors:  Stig Ove Hjelmevoll; Merethe Elise Olsen; Johanna U Ericson Sollid; Håkon Haaheim; Magnus Unemo; Vegard Skogen
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

8.  Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.

Authors:  Julius Kapala; Kathy Biers; Michael Cox; Margaret Kamionka; Jeff Sumner; Ramandeep Toor; Jodi Gilchrist; Dan Jang; Marek Smieja; Max Chernesky
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

9.  Comparison of COBAS AMPLICOR Neisseria gonorrhoeae PCR, including confirmation with N. gonorrhoeae-specific 16S rRNA PCR, with traditional culture.

Authors:  Dirk S Luijt; Petra A J Bos; Anton A van Zwet; Pieter C van Voorst Vader; Jurjen Schirm
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.